News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Merck & Co., Inc., Novartis Corporation Blood Cancer Drugs May Shrink Child Tumors, Study Finds
March 30, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- A family of blood cancer drugs made by Merck & Co. and Novartis AG (NOVN) may help treat a rare and incurable disease that causes large tumors to form in the chest, head and neck of children, Harvard researchers report.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Merck & Co.
MORE ON THIS TOPIC
Cancer
BMS’ Krazati kneels to chemo in confirmatory colorectal cancer trial
July 7, 2026
·
2 min read
·
Tristan Manalac
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
July 6, 2026
·
2 min read
·
Gabrielle Masson
Rare diseases
BridgeBio touts kidney benefits for Attruby, differentiating from amyloidosis competitors
July 6, 2026
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Merck axes Alzheimer’s study, adding to partner Neuphoria’s mounting woes
July 2, 2026
·
2 min read
·
Tristan Manalac